Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Medication Systems (IMS) is a specialized pharmaceutical company focused on the development and manufacture of emergency medication delivery systems. The company is best known for its proprietary Min-I-Jet and Luer-Jet pre-filled syringe systems, which are designed for rapid administration in critical care and emergency settings. IMS provides a wide range of injectable drugs, including cardiovascular agents, respiratory treatments, and reversal agents like naloxone. Since its acquisition by Amphastar Pharmaceuticals, IMS continues to operate as a key subsidiary, leveraging its specialized manufacturing capabilities to supply hospitals and emergency medical services globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Medication.